Salivary Duct Carcinoma: New Developments—Morphological Variants Including Pure In Situ High Grade Lesions; Proposed Molecular Classification
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kleinsasser O, Klein HH, Hübner G. Speichelgangcarcinom: ein den milchgangcarcinomen der brüstdruse analoge gruppe von speicheldrüsentumoren [Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma]. Archiv für Klin Exper Ohren Nasen Kehlkopfheilkunde. 1968;192:100–15.
Ellis GL, Auclair PL. Salivary duct carcinoma. In: AFIP, editor. Atlas of tumor pathology, fourth series, fascicle 9: tumors of the salivary glands. Washington DC: American Registry of Pathology; 2008. p. 322–32.
Brandwein-Gensler MS, Skálová A, Nagao T. Salivary duct carcinoma. In: Barnes EL, Eveson JW, Reichart P, Sidransky D, editors. Chapter 5, tumours of the salivary glands world health organization classification of tumours pathology and genetics of head and neck tumours. Lyon, France: IARC Press; 2005. p. 236–7.
Simpson RHW, Di Palma S. Selected recent advances in the pathology of salivary neoplasms. Diagn Histopathol. 2010;16:276–86.
van Heerden WFP, Raubenheimer EJ, Swart TJP, Boy SC. Intraoral salivary duct carcinoma: a report of 5 cases. J Oral Maxillofac Surg. 2003;61:126–31.
Simpson RHW, Reis-Filho JS, Pereira EM, Ribeiro AC, Abdulkadir A. Polymorphous low grade adenocarcinoma of the salivary glands with transformation to high grade carcinoma. Histopathology. 2002;41:250–9.
Lewis JE, McKinney BC, Weiland LH, Ferreiro JA, Olsen KD. Salivary duct carcinoma: clinicopathologic and immunohistochemical review of 26 cases. Cancer. 1996;77:223–30.
Gnepp DR, Henley JD, Simpson RHW, Eveson JW. Salivary gland (major and minor) and lacrimal gland. Chapter 6. In: Gnepp DR, editor. Diagnostic surgical pathology of the head and neck. 2nd ed. Philadelphia: WB Saunders; 2009. p. 413–562.
Hogg RP, Ayshford C, Watkinson JC. Parotid duct carcinoma arising in bilateral chronic sialadenitis. J Laryngol Otol. 1999;113:686–8.
Gill J, Angelo N, Yeong ML, McIvor N. Salivary duct carcinoma arising in IgG4- related autoimmune disease of the parotid gland. Hum Pathol. 2009;40:881–6.
Di Palma S, Simpson RHW, Skálová A, Leivo I. Chapter 5: major and minor salivary glands. In: Cardesa A, Slootweg PJ, editors. Pathology of the head and neck pathology. Berlin: Springer; 2006. p. 131–70.
de Araújo VC, Loducca SVL, Sobral APV, Kowalski AL, Soares F, de Araújo NS. Salivary duct carcinoma: cytokeratin 14 as a marker of in situ intraductal growth. Histopathology. 2002;41:244–9.
Afzelius LE, Cameron WR, Svensson C. Salivary duct carcinoma–a clinicopathologic study of 12 cases. Head Neck Surg. 1987;9:151–6.
Brandwein MS, Jagirdar J, Patil J, Biller H, Kaneko M. Salivary duct carcinoma (cribriform salivary carcinoma of excretory ducts): a clinicopathologic and immunohistochemical study of 12 cases. Cancer. 1990;65:2307–14.
Garland TA, Innes DJ Jr, Fechner RE. Salivary duct carcinoma: an analysis of four cases with review of literature. Am J Clin Pathol. 1984;81:436–41.
Guzzo M, Di Palma S, Grandi C, Molinari R. Salivary duct carcinoma: clinical characteristics and treatment strategies. Head Neck. 1997;19:126–33.
Martinez-Barba E, Cortes-Guardiola JA, Minguela-Puras A, Torroba-Caron A, Mendez-Trujillo S, Bermejo-Lopez J. Salivary duct carcinoma: clinicopathological and immunohistochemical studies. J Cranio Maxillofac Surg. 1997;25:328–34.
Simpson RHW, Clarke TJ, Sarsfield PTL, Babajews AV. Salivary duct adenocarcinoma. Histopathology. 1991;18:229–35.
Simpson RHW, Robertson NJ, Arora DS, Saunders MW. Salivary duct carcinoma: a cytological and histopathological study. Cytopathology. 1996;7:141–4.
Simpson RHW, Prasad A, Lewis JE, Skálová A, David L. Mucin-rich variant of salivary duct carcinoma: a clinicopathological and immunohistochemical study of four cases. Am J Surg Pathol. 2003;27:1070–9.
Nikitakis NG, Tosios KI, Papanikolaou VS, Rivera H, Papanicolaou SI, Ioffe OB. Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors. Modern Pathol. 2004;17:407–15.
Kapadia SB, Barnes L. Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Modern Pathol. 1998;11:1033–8.
Di Palma S, Skálová A, Vanĕček T, Simpson RHW, Stárek I, Leivo I. Non-invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER-2/neu and MIB1 immunohistochemistry. Histopathology. 2005;46:144–52.
Jaehne M, Jäkel KT, Röser K, Ußmüller J, Löning T. Pilotstudie zur prognostischen Wertigkeit der Her-2 Genamplifikation und Proliferationsaktivität beim Speichelgangkarzinom der großen Kopfspeicheldrüsen [About the prognostic value of Her-2 gene-amplification and cell-proliferation in salivary duct carcinoma of the major salivary glands—a pilot-study]. Laryngorhinootologie. 2001;80:525–9.
Skálová A, Stárek I, Vanĕček T, Kučerová V, Plank L, Szépe P, Di Palma S, Leivo I. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in situ hybridization and immunohistochemistry. Histopathology. 2003;42:348–56.
Sugano S, Mukai K, Tsuda H, et al. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Laryngoscope. 1992;102:923–7.
Johnson CJ, Barry MB, Vasef MA, De Young BR. HER-2/neu expression in salivary duct carcinoma: an immunohistochemical and chromogenic in situ hybridization study. Appl Immunohistochem Mol Morphol. 2008;16:54–8.
Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF. American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118–45.
Di Palma S, Simpson RHW, Marchiò C, Skálová A, Ungari M, Sandison A, Whitaker S, Parry S, Reis-Filho JS. Salivary duct carcinomas can be classified into luminal andogen receptor-positive, HER2 and basal-like phenotypes. Histopathology. 2012;61:629–43.
Williams MD, Roberts DB, Kies MS, Mao L, Weber RS, El-Naggar AK. Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance. Clin Cancer Res. 2010;16:2266–74.
Williams MD, Roberts D, Blumenschein GR Jr, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am J Surg Pathol. 2007;31:1645–52.
Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen and progesterone receptors in salivary gland tumors: frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol. 2003;119:801–6.
Barnes L, Rao U, Contis L, Krause J, Schwartz A, Scalamogna P. Salivary duct carcinoma. Part II. Immunohistochemical evaluation of 13 cases for estrogen and progesterone receptors, cathepsin D, and c-erbB-2 protein. Oral Surg Oral Med Oral Pathol. 1994;78:74–80.
Wick MR, Ockner DM, Mills SE, Ritter JH, Swanson PE. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol. 1998;109:75–84.
Fan CY, Wang J, Barnes EL. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am J Surg Pathol. 2000;24:579–86.
Isola JJ. Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J Pathol. 1993;170:31–5.
Moinfar F, Okcu M, Tsybrovskyy O, et al. Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. Cancer. 2003;98:703–11.
Moriki T, Ueta S, Takahashi T, Mitani M, Ichien M. Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis. Cancer (Cancer Cytopathol). 2001;93:344–50.
Kay PA, Roche PC, Olsen KD, Lewis JE. Salivary duct carcinoma: immunohistochemical analysis of androgen receptor, prostate markers and HER-2/neu oncoprotein in 40 cases. [Abstract]. Mod Pathol. 2001;14:150A.
Fan C-Y, Melhem MF, Hosal S, Grandis R, Barnes EL. Expression of androgen receptor, epidermal growth factor receptor, and transforming growth factor α in salivary duct carcinoma. Arch Otolaryngol Head Neck Surg. 2001;127:1075–9.
Mukunyadzi P, Ai L, Portilla D, Barnes EL, Fan C-Y. Expression of peroxisome proliferators-activated receptor gamma in salivary duct carcinoma: immunohistochemical analysis of 15 cases. Mod Pathol. 2003;16:1218–23.
Hui KK, Batsakis JG, Luna MA, MacKay B, Byers RM. Salivary duct adenocarcinoma: a high grade malignancy. J Laryngol Otol. 1986;100:105–14.
Cerilli LA, Swartzbaugh JR, Saadut R, Marshall CE, Rumpel CA, Moskaluk CA, Frierson HF Jr. Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. Hum Pathol. 1999;30:1242–6.
Hoang MP, Callender DL, Sola-Gallego JJ, Huang Z, Sneige N, Luna MA, Batsakis JG, El-Naggar AK. Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma. Int J Oncol. 2001;19:865–71.
Mutoh H, Nagata H, Ohno K, Numata T, Nagao T, Nagao K, Konno A. Analysis of the p53 gene in parotid gland cancers: a relatively high frequency of mutations in low- grade mucoepidermoid carcinomas. Int J Oncol. 2001;18:781–6.
Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer. 2005;103:2526–33.
Leivo I, Jee KJ, Heikinheimo K, Laine M, Ollila J, Nagy B, Knuutila S. Characterization of gene expression in major types of salivary gland carcinomas with epithelial differentiation. Cancer Genet Cytogenet. 2005;156:104–15.
Seethala RR, Dacic S, Cieply K, Kelly LM, Nikiforova MN. A reappraisal of the MECT1-MAML2 translocation in salivary mucoepidermoid carcinomas. Am J Surg Pathol. 2010;34:1106–21.
Brill LB, Kanner WA, Fehr A, Andrén Y, Moskaluk CA, Löning T, Stenman G, Frierson HF. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms. Mod Pathol. 2011;24:11691176.
Michal M, Skálová A, Mukenšnabl P. Invasive micropapillary carcinoma of the parotid gland arising in mucinous cystadenoma. Virchow Archiv. 2000;437:465–8.
Nagao T, Gaffey TA, Visscher DW, Kay PA, Minato H, Serizawa H, Lewis JE. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance. Am J Surg Pathol. 2004;28:319–26.
Henley JD, Summerlin D-J, Potter D, Tomich C. Intraoral mucin-rich salivary duct carcinoma. Histopathology. 2005;47:436–7.
Kaku T, Ohuchi T, Satoh M, Ikeda T, Asanuma H, Azuma K, Kobayashi H. A case of mucin-rich salivary duct carcinoma ex pleomorphic adenoma. [Abstract]. Virchows Arch. 2005;447:341–2.
Yakirevich E, Sabo E, Klorin G, Alos L, Cardesa A, Ellis GL, Shumway BS, Gnepp DR. Primary mucin-producing tumours of the salivary glands: a clinicopathological and morphometric study. Histopathology. 2010;57:395–409.
Henley JD, Seo IS, Dayan D, Gnepp DR. Sarcomatoid salivary duct carcinoma of the parotid gland. Hum Pathol. 2000;31:208–13.
Nagao T, Gaffey TA, Serizawa H, Iwaya K, Watanabe A, Yoshida T, Yamazaki K, Sageshima M, Lewis JE. Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases and review of the literature. Am J Clin Pathol. 2004;122:222–31.
Tse LLY, Finkelstein SD, Siegler RW, Barnes LE. Osteoclast-type giant cell neoplasm of salivary gland. A microdissection-based comparative genotyping assay and literature review. Am J Surg Pathol. 2004;28:953–61.
Simpson RHW, Di Palma S. Carcinomas of the salivary gland. In: Pignatelli M, Underwood JCE, editors. Recent advances in histopathology 22. London: Royal Society of Medicine Press; 2007. p. 17–43.
Anderson C, Muller R, Piorkowski R, Knibbs DR, Vignoti P. Intraductal carcinoma of major salivary gland. Cancer. 1992;69:609–14.
Cheuk W, Miliauskas JR, Chan JKC. Intraductal carcinoma of the oral cavity: a case report and a reappraisal of the concept of pure ductal carcinoma in situ in salivary duct carcinoma. Am J Surg Pathol. 2004;28:266–70.
Tatemoto Y, Ohno A, Osaki T. Low malignant intraductal carcinoma on the hard palate: a variant of salivary duct carcinoma? Oral Oncol Eur J Cancer. 1996;32B:275–7.
Watatani K, Shirasuna K, Aikawa T, Matsuya T. Intraductal carcinoma of the tongue: report of a case. Int J Oral Maxillofac Surg. 1991;20:175–6.
Simpson RHW, Desai S, Di Palma S. Salivary duct carcinoma in situ of the parotid gland. Histopathology. 2008;53:416–25.
Delgado R, Klimstra D, Albores Saavedra J. Low grade salivary duct carcinoma. A distinctive variant with a low grade histology and a predominant intraductal growth pattern. Cancer. 1996;78:958–67.
Brandwein-Gensler M, Hille J, Wang BY, Urken M, Gordon R, Wang LJ, Simpson JR, Simpson RH, Gnepp DR. Low-grade salivary duct carcinoma: description of 16 cases. Am J Surg Pathol. 2004;28:1040–4.
Weinreb I. Intraductal carcinoma of salivary gland (so-called low-grade cribriform cystadenocarcinoma) arising in an intraparotid lymph node. Head Neck Pathol. 2011;5:321–5.
Weinreb I, Tabanda-Lichauco R, van der Kwast T, Perez-Ordonez B. Low-grade intraductal carcinoma of salivary gland: report of 3 cases with marked apocrine differentiation. Am J Surg Pathol. 2006;30:1014–21.
Kusafuka K, Itoh H, Sugiyama C, Nakajima T. Low-grade salivary duct carcinoma of the parotid gland: report of a case with immunohistochemical analysis. Med Mol Morphol. 2010;43:178–84.
Chu PG, Weiss LM. Review. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40:403–39.
Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–52.
Farmer P, Bonnefoi H, Becette V, et al. Identification of molecular apocrine breast tumours by microarray analysis. Oncogene. 2005;24:4660–71.
Hu Z, Fan C, Oh DS, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics. 2006;7:96.
Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869–74.
Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10:5367–74.
Hungermann D, Roeser K, Buerger H, Jäkel T, Löning T, Herbst H. Speichelgangkarzinome. Pathologe. 2005;26:353–8.
Locati LD, Bossi B, Rinaldi GR, Bergamini CB, Quattrone Q, Staurengo S, Pilotti S, Licitra L. Anti-androgen therapy in recurrent and/or metastatic salivary glands carcinoma (RSGC). [Abstract]. Ann Oncol 2006; 16: iii–38.
di Palma S, Whitaker S, Potter K, Pitkin L. Carcinoma ex pleomorphic adenoma successfully treated with trastuzumab and radiotherapy [abstract]. Virchow Archiv. 2012;461(Suppl 1):S144.